Average Insider

Where insiders trade, we follow

$NMRA
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; and NMRA-266, which is in the phase 1 clinical trial for the treatment of schizophrenia and other neuropsychiatric disorders. In addition, its preclinical phase product includes NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.
Healthcare
Sector
Biotechnology
Industry
Daljit Singh Aurora
CEO
110
Employees
$1.63
Current Price
$581.47M
Market Cap
52W Low$0.83
Current$1.6328.4% above low, 71.6% below high
52W High$3.65

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys00---
Sells00--
2 monthsBuys00---
Sells00--
3 monthsBuys00---
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Aug 21, 2026
Aurora Daljit Singh
Chief Operating and Development Officer
Sale21,055$1.60$33,599.57View Details
Aug 21, 2026
Aurora Daljit Singh
Chief Operating and Development Officer
Sale20,553$1.59$32,779.98View Details
Aug 20, 2026
Aurora Daljit Singh
Chief Operating and Development Officer
Sale67,741$1.51$102,586.97View Details
Aug 20, 2026
Aurora Daljit Singh
Chief Operating and Development Officer
Sale66,711$1.51$101,000.45View Details
Aug 19, 2026
Aurora Daljit Singh
Chief Operating and Development Officer
Sale30,918$1.65$50,887.94View Details
Aug 19, 2026
Aurora Daljit Singh
Chief Operating and Development Officer
Sale31,000$1.65$51,029.10View Details
9 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Nov 16, 2026
EPS
Estimated-$0.20
Actual-$0.18
Beat
Revenue
Estimated$16.00K
Actual$16.00K
Beat
Nov 13, 2026
EPS
Estimated-$0.20
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Nov 12, 2026
EPS
Estimated-$0.20
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Nov 9, 2026
EPS
Estimated-$0.20
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Nov 5, 2026
EPS
Estimated-$0.19
ActualN/A
Revenue
EstimatedN/A
ActualN/A
4 more earnings records available โ€” create a free account to see 12 months of history
Version: v26.11.1